Income Statement
Balance Sheet
Cash Flow
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 1.8M | 1.1M | 1.4M | 2.7M |
| General And Administrative Expense | 1.8M | 1.1M | 1.4M | 2.7M |
| Other Operating Expenses | 477,000 | 502,000 | 523,000 | 684,000 |
| Operating Expense | 2.2M | 1.6M | 2.0M | 3.3M |
| Operating Income | -2.2M | -1.6M | -2.0M | -3.3M |
| EBIT | -2.2M | -1.6M | -2.0M | -3.3M |
| Other Income Expense | -324,000 | 130,000 | 11,000 | -19.2M |
| Other Non Operating Income Expenses | 6,000 | -- | -- | 9,000 |
| Special Income Charges | 0.00 | -215,000 | 0.00 | -19.2M |
| Gain On Sale Of Security | -330,000 | 345,000 | 11,000 | -46,000 |
| Pretax Income | -2.6M | -1.5M | -2.0M | -22.6M |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -2.6M | -1.5M | -2.0M | -22.6M |
| Net Income From Continuing Operation Net Minority Interest | -2.6M | -1.5M | -2.0M | -22.6M |
| Net Income Including Noncontrolling Interests | -2.6M | -1.5M | -2.0M | -22.6M |
| Net Income Common Stockholders | -2.6M | -1.5M | -2.0M | -22.6M |
| Net Income | -2.6M | -1.5M | -2.0M | -22.6M |
| EBITDA | -2.2M | -1.6M | -2.0M | -3.3M |
| Normalized EBITDA | -1.9M | -1.7M | -2.0M | 15.9M |
| Basic EPS | -0.10 | -0.10 | -0.20 | -2.10 |
| Diluted EPS | -0.10 | -0.10 | -0.20 | -2.10 |
| Basic Average Shares | 25.0M | 18.2M | 12.3M | 10.9M |
| Diluted Average Shares | 25.0M | 18.2M | 12.3M | 10.9M |
| Total Unusual Items | -330,000 | 130,000 | 11,000 | -19.2M |
| Total Unusual Items Excluding Goodwill | -330,000 | 130,000 | 11,000 | -19.2M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -2.2M | -1.6M | -2.0M | -3.3M |
| Diluted NI Availto Com Stockholders | -2.6M | -1.5M | -2.0M | -22.6M |
| Impairment Of Capital Assets | 0.00 | 215,000 | 0.00 | 19.2M |
| Insurance And Claims | 73,000 | 79,000 | 91,000 | 95,000 |
| Net Income Continuous Operations | -2.6M | -1.5M | -2.0M | -22.6M |
| Other Gand A | 670,000 | 787,000 | 690,000 | 1.2M |
| Salaries And Wages | 1.0M | 222,000 | 668,000 | 1.4M |
| Total Expenses | 2.2M | 1.6M | 2.0M | 3.3M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Cash And Cash Equivalents | 2.1M | 1.5M | 2.2M | 4.8M |
| Cash Cash Equivalents And Short Term Investments | 2.5M | 1.5M | 2.2M | 4.8M |
| Cash Financial | -- | 1.5M | 2.2M | 4.8M |
| Other Short Term Investments | 321,000 | 0.00 | -- | -- |
| Accounts Receivable | 131,000 | 27,000 | 69,000 | 521,000 |
| Receivables | 131,000 | 27,000 | 69,000 | 521,000 |
| Prepaid Assets | 137,000 | 144,000 | 86,000 | -- |
| Current Assets | 2.7M | 1.7M | 2.4M | 5.4M |
| Gross PPE | 16.2M | 17.2M | 14.7M | 11.9M |
| Accumulated Depreciation | -1.4M | -1.3M | -1.2M | -1.1M |
| Net PPE | 14.9M | 16.0M | 13.5M | 10.7M |
| Total Non Current Assets | 15.2M | 16.1M | 13.7M | 10.9M |
| Total Assets | 18.0M | 17.8M | 16.1M | 16.3M |
| Accounts Payable | 604,000 | 202,000 | 405,000 | 636,000 |
| Payables | 604,000 | 202,000 | 405,000 | 636,000 |
| Payables And Accrued Expenses | 672,000 | 248,000 | 464,000 | 681,000 |
| Current Accrued Expenses | 68,000 | 46,000 | 59,000 | 45,000 |
| Current Liabilities | 672,000 | 248,000 | 464,000 | 681,000 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 672,000 | 248,000 | 464,000 | 681,000 |
| Common Stock | 192.9M | 191.4M | 187.9M | 186.2M |
| Capital Stock | 192.9M | 191.4M | 187.9M | 186.2M |
| Retained Earnings | -190.4M | -187.8M | -186.4M | -184.4M |
| Gains Losses Not Affecting Retained Earnings | -732,000 | -850,000 | -284,000 | -247,000 |
| Common Stock Equity | 17.3M | 17.5M | 15.6M | 15.6M |
| Stockholders Equity | 17.3M | 17.5M | 15.6M | 15.6M |
| Total Equity Gross Minority Interest | 17.3M | 17.5M | 15.6M | 15.6M |
| Total Capitalization | 17.3M | 17.5M | 15.6M | 15.6M |
| Net Tangible Assets | 17.3M | 17.5M | 15.6M | 15.6M |
| Tangible Book Value | 17.3M | 17.5M | 15.6M | 15.6M |
| Working Capital | 2.1M | 1.5M | 1.9M | 4.7M |
| Invested Capital | 17.3M | 17.5M | 15.6M | 15.6M |
| Share Issued | 29.2M | 24.7M | 15.1M | 12.1M |
| Ordinary Shares Number | 29.2M | 24.7M | 15.1M | 12.1M |
| Financial Assets | 247,000 | -- | -- | -- |
| Foreign Currency Translation Adjustments | -732,000 | -850,000 | -284,000 | -247,000 |
| Machinery Furniture Equipment | 25,000 | 25,000 | 25,000 | 25,000 |
| Non Current Prepaid Assets | 125,000 | 89,000 | 175,000 | 201,000 |
| Other Equity Interest | 15.5M | 14.8M | 14.4M | 14.0M |
| Line Item | FY 2024Dec 31, 2024 | FY 2023Dec 31, 2023 | FY 2022Dec 31, 2022 | FY 2021Dec 31, 2021 |
|---|---|---|---|---|
| Operating Cash Flow | -882,000 | -1.2M | -1.1M | -2.1M |
| Cash Flow From Continuing Operating Activities | -882,000 | -1.2M | -1.0M | -2.1M |
| Stock Based Compensation | 794,000 | 126,000 | 548,000 | 1.1M |
| Change In Working Capital | 327,000 | -259,000 | 236,000 | -216,000 |
| Change In Receivables | -104,000 | 6,000 | 352,000 | -268,000 |
| Change In Payables And Accrued Expense | 424,000 | -243,000 | -217,000 | 52,000 |
| Other Non Cash Items | 269,000 | 159,000 | 58,000 | 354,000 |
| Capital Expenditure | -92,000 | -71,000 | -3.0M | -6.2M |
| Purchase Of PPE | -92,000 | -71,000 | -67,000 | -67,000 |
| Net PPE Purchase And Sale | 2.8M | -71,000 | -67,000 | -67,000 |
| Investing Cash Flow | 311,000 | -1.3M | -2.8M | -6.3M |
| Cash Flow From Continuing Investing Activities | 311,000 | -1.3M | -2.8M | -6.3M |
| Issuance Of Capital Stock | 1.2M | 2.4M | 1.3M | 9.1M |
| Net Common Stock Issuance | 1.2M | 2.4M | 1.3M | 9.1M |
| Financing Cash Flow | 1.2M | 2.4M | 1.3M | 9.1M |
| Cash Flow From Continuing Financing Activities | 1.2M | 2.4M | 1.3M | 9.1M |
| Effect Of Exchange Rate Changes | 27,000 | -566,000 | -37,000 | -247,000 |
| Changes In Cash | 587,000 | -128,000 | -2.6M | 617,000 |
| Beginning Cash Position | 1.5M | 2.2M | 4.8M | 4.5M |
| End Cash Position | 2.1M | 1.5M | 2.2M | 4.8M |
| Free Cash Flow | -974,000 | -1.3M | -4.1M | -8.3M |
| Asset Impairment Charge | 0.00 | 215,000 | 0.00 | 19.2M |
| Capital Expenditure Reported | -- | -1.5M | -2.9M | -6.1M |
| Change In Prepaid Assets | 7,000 | -22,000 | 101,000 | -- |
| Common Stock Issuance | 1.2M | 2.4M | 1.3M | 9.1M |
| Net Income From Continuing Operations | -2.6M | -1.5M | -2.0M | -22.6M |
| Net Other Investing Changes | -2.4M | -1.3M | 210,000 | -146,000 |
| Sale Of PPE | 2.8M | 0.00 | -- | -- |
| Unrealized Gain Loss On Investment Securities | 284,000 | 0.00 | -- | -- |